Patent ID: 11944837
Assignee: ASHA MEDICAL, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 17:
18. The system of claim 17, wherein the AP magnetic field is further adapted to modify the cancer microenvironment (TME) by at least one of:
modulating blood vessels surrounding the cancer cells;
modulating fibroblasts proximate to the cancer cells;
modulating immune cell signaling molecules proximate to the cancer cells;
modulating an extracellular matrix surrounding the cancer cells;
modulating resident host cells;
modulating infiltrating host cells;
modulating secreted factors proximate to the cancer cells;
modulating proteins surrounding the cancer cells;
modulating a concentration of pericycles proximate to the cancer cells; and
modulating a concentration of adipocytes proximate to the cancer cells.